BEIJING ENT (00392) · Company profile · Eqvero

BEIJING ENT

00392HKEX

Unit: CNY	FY2025	FY2024	FY2023
Revenue	87.23 bn CNY	84.06 bn CNY	82.31 bn CNY
Cost of revenue	70.66 bn CNY	68.48 bn CNY	67.52 bn CNY
Research and development expense	1.79 bn CNY	1.97 bn CNY	1.72 bn CNY
Selling, general and administrative expense	8.45 bn CNY	8.03 bn CNY	8.28 bn CNY
Operating profit after depreciation	2.4 bn CNY	2.88 bn CNY	1.95 bn CNY
Operating profit before depreciation	7.04 bn CNY	7.04 bn CNY	6.06 bn CNY
EBIT	2.4 bn CNY	2.88 bn CNY	1.95 bn CNY
EBITDA	7.04 bn CNY	7.04 bn CNY	6.06 bn CNY
Interest expense	2.3 bn CNY	2.58 bn CNY	2.9 bn CNY
Profit before tax	7.76 bn CNY	7.55 bn CNY	7.27 bn CNY
Income tax expense	1.11 bn CNY	1.23 bn CNY	865.89 m CNY
Income before extraordinary items	5.06 bn CNY	5.12 bn CNY	5.5 bn CNY
Common dividends	1.86 bn CNY	1.86 bn CNY	1.82 bn CNY
Total dividends	1.86 bn CNY	1.86 bn CNY	1.82 bn CNY

Quotes are end-of-day data. Content is for research purposes and is not investment advice.